Pacific Biosciences of California (PACB)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q2 2021 | |||||
| ≡ | Viking Global Investors | Add 334.20% | 980,324 | 0.11 | |
| Q3 2020 | |||||
| ≡ | Viking Global Investors | Buy | 4,518,623 | 0.16 | |
| Q4 2018 | |||||
| ≡ | Prem Watsa - Fairfax Financial Holdings | Buy | 160,000 | 0.09 | |
| Q1 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 8.46% | 950,000 | 0.02 | |
| Q4 2017 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 5.84% | 619,150 | 0.02 | |
| Q2 2017 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 16.86% | 1,530,070 | 0.07 | |
| ≡ | Meridian Contrarian Fund | Add 15.95% | 175,000 | 0.12 | |
| Q1 2017 | |||||
| ≡ | Meridian Contrarian Fund | Add 47.08% | 351,323 | 0.35 | |
| Q4 2016 | |||||
| ≡ | Meridian Contrarian Fund | Add 76.27% | 322,854 | 0.23 | |
| Q3 2016 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 16.30% | 1,274,855 | 0.14 | |
| ≡ | Meridian Contrarian Fund | Buy | 423,300 | 0.75 | |
| Q2 2016 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 3.43% | 259,540 | 0.02 | |
| Q4 2015 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 1.41% | 105,234 | 0.02 | |
| Q3 2015 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 5.59% | 395,000 | 0.02 | |
| Q1 2015 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 9.31% | 601,250 | 0.06 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.